SCBM H9
Avian Influenza (Subtype H9) Vaccine, Inactivated (Strain SS)
Product Features
1. Unique Patent Strain (Strain SS )
The patented avian influenza subtype H9 strain SS offers strong immunogenicity and a broad antigenic spectrum, providing effective protection against various subtype H9 avian influenza infections.
2. High Viral Titer and Superior Antibody Response
Advanced antigen ultrafiltration and concentration technology ensures highly purified antigens, resulting in excellent antibody uniformity, high antibody levels, and prolonged immunity duration.
3. Advanced Process Ensures Product Stability
Utilizing advanced equipment and processes including centrifugation and filtration, the vaccine maintains low residual endotoxin (≤50 EU/ml), total protein content (≤1mg/ml), and formaldehyde content (≤0.02%, only one-tenth of the national standard). It features uniform particle size, low viscosity, and high stability.
4. High-Quality Adjuvant with Minimal Stress
Formulated with imported food-grade adjuvants and raw materials to minimize immunization stress, promote rapid absorption, and ensure safer injection.
[Ingredients]
The product is prepared with imported quality adjuvant and composed of inactivated avian influenza virus (subtype H9). Before inactivation the virus concentration is ≥5×107.0EID50/ml.
[Indication]
It is used to prevent avian influenza virus (subtype H9) infection in chickens, for healthy chickens only. Immunity will generate within 21 days, and immunity period is 6 months.
[Properties] Milky white emulsion
[Dosage & Administration]
Subcutaneous back of the neck or imtramuscular injection.
0.25ml/bird for chickens 5-15 days;
0.5ml/bird for chickens over 15 days .
[Storage & Shelf life] 2~8℃, valid for 24 months
[Specification] 250ml/bottle 500ml/bottle
[Reg No.] SYSZ190912182